CapsCanada
Specialty Enzymes

Eighth Annual NIE New Ingredient Awards Call for Entries

CBD


CV Sciences and UC San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence

by Shari Barbanel | August 11, 2021

CV Sciences, Inc. (San Diego, CA) has announced progress toward its goal of developing and commercializing a CBD-based pharmaceutical to treat nicotine addiction in smokeless tobacco users. The company, in collaboration with researchers from the University of California, San Diego (UC San Diego), published a preclinical study demonstrating the efficacy of chronic CBD treatment in ...

Verdant Nature and Credo Science Form Alliance to Develop Unique Endocannabinoid Products

by Shari Barbanel | August 2, 2021

Verdant Nature, LLC (Wyoming), manufacturer of the Verdant Oasis brand, has announced its partnership with CReDO Science (Austin, TX) headed by world renowned medical cannabinoid expert Ethan Russo, MD. CReDO Science has aligned with Verdant Nature to consult on the development of proprietary, high-quality hemp-derived formulations for companies positioning their products in the CBD category. ...

New Draft Legislation Sets Safe Level of Consumption for CBD Products

by Shari Barbanel | July 26, 2021

New draft legislation includes a provision directing the U.S. Food and Drug Administration (FDA) to set a safe level of consumption for CBD products. The provision is part of a broader bill introduced by Senator Chuck Schumer (D-NY) that would decriminalize cannabis at the federal level. “Setting a safe level of consumption for CBD products ...

Storytelling for Greater PR Media Placement

by Sheldon Baker | July 1, 2021

Being able to wrap a personal story around a company or product when pitching an editor or broadcast producer can often garner greater attention and produce better PR results. For example, when the appetite suppressant ingredient CitriMax was first introduced by InterHealth a few decades ago (it seems like just the other day as I ...

DSM Partners With Cannabinoid Ingredient Manufacturer Mile High Labs

by Shari Barbanel | June 16, 2021

Royal DSM (Heerlen, The Netherlands) has announced it has entered into a broad commercial partnership with industry-leading cannabinoid ingredients and finished products manufacturer, Mile High Labs (MHL, Broomfield, CO). The partnership extends DSM’s capabilities as an innovative, end-to-end partner in nutrition and health—creating a platform from which leading consumer products companies can deliver novel, health-benefit ...

Open Book Extracts Raises $11.5M Series B Funding Round to Accelerate Global Growth

by Shari Barbanel | June 2, 2021

Open Book Extracts (OBX), a Roxboro, NC-based ingredient manufacturer and product development house for cannabinoid-enabled products, announced the close of an $11.5 million Series B equity financing round through its parent company Steady State. This round of funding, co-led by Nortecapital and KEY Investment Partners, is a resounding vote of confidence for OBX and its ...

Bipartisan Legislation Introduced Would Create Regulatory Pathways for Use of Hemp-derived CBD in Dietary Supplements and Conventional Food

by Shari Barbanel | May 26, 2021

On May 19, Senators Ron Wyden and Jeff Merkley (D-OR) and Senator Rand Paul (R-KY) introduced bipartisan legislation that would protect public health by providing legal clarity in the hemp and hemp-derived cannabidiol (CBD) product marketplace. The Hemp Access and Consumer Safety Act of 2021 would amend the Federal Food, Drug and Cosmetic Act (FD&CA) ...

Compliance and Improving Quality—Assessing an Industry’s Vital Signs

by James Gormley | May 6, 2021

The panel: Gene Bruno, Vice President of Scientific & Regulatory Affairs, Twinlab, Boca Raton, FL, www.twinlab.com Dieng Bui, Vice President of Quality & Regulatory Affairs, Lief Labs, Valencia, CA, https://lieflabs.com Nena Dockery, Scientific and Regulatory Affairs Manager, Stratum Nutrition, Carthage, MO, www.stratumnutrition.com Stefan Gafner, PhD, American Botanical Council, Austin, TX, http://herbalgram.org Haley Gershon, Marketing Manager, ...

FDA Warns Selling of Topical CBD Products Violates FD&C Act

by Shari Barbanel | March 29, 2021

On March 22, the U.S. Food and Drug Administration (FDA) stated that it has issued warning letters to two companies for selling topical pain relief products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). Specifically, the warning letters addressed the illegal marketing of unapproved drugs ...

New Hampshire Becomes Latest State to Propose CBD Regs to Fill FDA Vacuum

by Shari Barbanel | January 27, 2021

As the U.S. Food and Drug Administration (FDA) continues to defy mounting requests from the U.S. Congress and the natural products industry to provide science-based and public health regulations for CBD, more states are rushing in to fill the vacuum. New Hampshire recently became the latest state to propose new state regulations for consumable hemp and CBD products. Kyle Turk, director for government affairs, ...

Don't Miss Out!

Sign up for Nutrition Industry Executive Digital Newsletter
Digital Newsletter
Subscribe to Nutrition Industry Executive Magazine
Nutrition Industry Executive Magazine

Industry Professionals
Stay Informed!

Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.

Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.

Featured Listings:


CapsCanada

Subscribe To Our Newsletter

Stay Informed! Breaking news, industry trends featured topics, and more.

Subscribe to our newsletter today!